Glaukos Corporation
GKOSMedical Devices
$242.48+33.65%As of Oct 29vs prior close
- Market cap
- $14.3B
- P/E (TTM)
- –
- P/E (FY1)
- 401.1×
- From 52W high
- 0.00%
- EPS (LTM)
- -$2.96
- Revenue (LTM)
- $690.3M
- Net margin
- -24.60%
- Dividend yield
- 0.00%
Nomior Score
55
Ascendant MoverTop 37% of the scored universe
Growth81
Quality40
Value29
Momentum81
Resilience38
Growth
+18.00%revenue a year over 9 fiscal years
FY16 $114.4MLTM $690.3M
Connections
Revenue to profitQ3 FY26
1% of revenue became net profit, up 13 pts on a year.
Who owns it
2funds, 1 tracked portfolio